A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing
Abstract The Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus needs a fast recognition of effective drugs to save lives. In the COVID-19 situation, finding targets for drug repurposing can be an effective way to present new fast treatments. We have designed a two-step solution to a...
Guardado en:
Autores principales: | Mahnaz Habibi, Golnaz Taheri, Rosa Aghdam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/040ee459edf44619b0834ddbe2d352b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing
por: Mahnaz Habibi, et al.
Publicado: (2021) -
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
por: Sepideh Sadegh, et al.
Publicado: (2020) -
A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing.
por: Nithishwer Mouroug Anand, et al.
Publicado: (2021) -
Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis
por: Habib MotieGhader, et al.
Publicado: (2021) -
Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing
por: Anastasiya Belyaeva, et al.
Publicado: (2021)